May 8, 2024 Am I a Genus? The Amgen case and its impact on genus patenting for biologics By Ella Hilder
April 5, 2023 NIH Refuses to Employ “March-In” Rights in Petition to Lower Cancer Drug Costs By Olivia Santiago
March 13, 2023 Affordable Prescriptions for Patients Act of 2023: Congress’s Effort to Reduce the Impact of Patent Evergreening on Drug Prices By Khushbu Shah